Stiripentol
Diacomit (stiripentol) is a small molecule pharmaceutical. Stiripentol was first approved as Diacomit on 2007-01-03. It is used to treat seizures in the USA. It has been approved in Europe to treat juvenile myoclonic epilepsy.
| Trade Name | Diacomit |
|---|---|
| Common Name | Stiripentol |
| Indication | juvenile myoclonic epilepsy, seizures |
| Drug Class |
